Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants
Status:
Completed
Trial end date:
2021-05-21
Target enrollment:
Participant gender:
Summary
Primary Objective:
- To evaluate the impact of food on the pharmacokinetics (PK) of rilzabrutinib following
single oral doses to healthy subjects.
- To evaluate the impact of formulation on the PK of rilzabrutinib following single oral
doses to healthy subjects
Secondary Objective:
- To assess the safety and tolerability of single oral doses of rilzabrutinib administered
under fasted and fed conditions